Physician profile
Ruben Reider
NPI 1891890968
$1,092.89
in general payments reported to CMS, 2019-2025
13 companies · $37.17 in 2025
The $37.17 reported for 2025 was less than what a typical Geriatric Medicine (Internal Medicine) provider received nationally (typical 2025 total: $123).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $236 · 2020: $71.33 · 2021: $325 · 2022: $229 · 2024: $195 · 2025: $37.17.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $232.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $231.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $304.85 | 2019-2021 | |
| Nestle Healthcare Nutrition INC. | $291.65 | 2021-2022 | |
| Aimmune Therapeutics, INC. | $122.08 | 2024 | |
| Novo Nordisk INC | $110.68 | 2021-2024 | Ozempic, Rybelsus |
| Lilly USA, LLC | $49.73 | 2022-2024 | Mounjaro, Zepbound |
| Amarin Pharma, INC. | $44.01 | 2020 | |
| Novartis Pharmaceuticals Corporation | $40.58 | 2021-2022 | |
| Astrazeneca Pharmaceuticals LP | $31.89 | 2019-2024 | Breztri |
| Boehringer Ingelheim Pharmaceuticals, INC. | $31.77 | 2022-2025 | Jardiance |
| Glaxosmithkline, LLC. | $19.75 | 2022 | |
| Globus Medical, INC. | $19.33 | 2025 | Senza |
| Philips North America LLC | $14.16 | 2020 | |
| Amgen INC. | $12.41 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ruben Reider listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.